GlassScriptPhysician profile
David W Cardona
NPI 1265466759
$18,431.03
in general payments reported to CMS, 2019-2025
51 companies · $3,114 in 2025
The $3,114 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,171 · 2020: $2,209 · 2021: $3,086 · 2022: $2,839 · 2023: $2,795 · 2024: $3,217 · 2025: $3,114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,125.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $3,321.32 | 2019-2025 | Repatha, Tezspire, Otezla |
| Novo Nordisk INC | $1,867.50 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,654.25 | 2019-2024 | Xifaxan, Trulance |
| Glaxosmithkline, LLC. | $1,479.19 | 2019-2025 | Trelegy Ellipta, Nucala, Shingrix |
| Astrazeneca Pharmaceuticals LP | $1,101.25 | 2019-2025 | Tezspire, Airsupra, Farxiga |
| Lilly USA, LLC | $924.14 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Amarin Pharma, INC. | $820.47 | 2019-2022 | |
| Abbvie INC. | $731.99 | 2019-2024 | Qulipta, Viberzi, Linzess |
| Boehringer Ingelheim Pharmaceuticals, INC. | $711.21 | 2019-2025 | Jardiance |
| Pfizer INC. | $406.42 | 2019-2025 | |
| Corcept Therapeutics | $382.75 | 2024-2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $358.58 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $357.48 | 2019-2025 | Rexulti |
| Esperion Therapeutics, INC. | $349.88 | 2022-2025 | Nexletol |
| Kowa Pharmaceuticals America, INC. | $333.43 | 2021-2023 | Livalo |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $316.04 | 2024-2025 | Ibsrela |
| Dexcom, INC. | $296.44 | 2021-2024 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $233.12 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $210.34 | 2022-2025 | |
| Becton, Dickinson and Company | $186.19 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $185.00 | 2023-2024 | Dupixent |
| Biohaven Pharmaceuticals, INC. | $179.93 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $172.74 | 2019-2024 | |
| Sunovion Pharmaceuticals INC. | $153.14 | 2019-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $139.12 | 2020-2025 | Caplyta |
| Sumitomo Pharma America, INC. | $133.47 | 2023-2025 | Gemtesa |
| Stryker Corporation | $133.08 | 2025 | Mako |
| Merck Sharp & Dohme LLC | $122.72 | 2019-2021 | |
| Mannkind Corporation | $117.36 | 2019-2022 | |
| Shield Therapeutics INC | $99.39 | 2023-2025 | Accrufer |
| Philips North America LLC | $94.90 | 2019-2025 | Vest Therapy Und |
| Sanofi Pasteur INC. | $89.55 | 2019-2023 | |
| Abbott Laboratories | $76.18 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $75.31 | 2022 | |
| Allergan, INC. | $59.19 | 2019-2020 | |
| Exact Sciences Corporation | $57.73 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Nevro Corp. | $56.58 | 2022 | |
| Baxter Healthcare | $55.11 | 2024-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Vest System Model 105 Home Care |
| Medtronic, INC. | $43.53 | 2022-2024 | Intellis Adaptivestim |
| Lifescan, INC. | $43.21 | 2020-2022 | |
| Gilead Sciences, INC. | $38.81 | 2022-2023 | |
| Phathom Pharmaceuticals, INC. | $38.03 | 2025 | Voquezna |
| Genzyme Corporation | $37.82 | 2023-2025 | |
| Xeris Pharmaceuticals, INC. | $37.48 | 2024-2025 | Gvoke Hypopen, Recorlev |
| Cranial Technologies, INC | $34.27 | 2025 | Doc Band |
| Horizon Therapeutics Plc | $27.17 | 2021 | |
| Astellas Pharma US INC | $27.03 | 2019-2021 | |
| Mylan Specialty L.P. | $20.29 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $14.37 | 2024 | |
| Idorsia Pharmaceuticals US INC | $13.59 | 2024 | Quviviq |
| Takeda Pharmaceuticals U.S.A., INC. | $12.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cardona listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.